New Promises and Challenges on Inflammation and Atherosclerosis: Insights From CANTOS and CIRT Trials

Front Cardiovasc Med. 2019 Jul 2:6:90. doi: 10.3389/fcvm.2019.00090. eCollection 2019.

¹ Helium-3 Biotech, South Perth, WA, Australia.
² Faculty of Health Sciences, School of Pharmacy and Biomedical Science, Curtin University, Perth, WA, Australia.

No abstract available

Keywords: acute coronary syndrome; atherosclerosis; cardiovascular risk; ischemic heart disease; vascular disease.